Federated Hermes, Inc. Castle Biosciences Inc Transaction History

Federated Hermes, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $7 Million - $10.7 Million	-139,747 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$58.92 - $97.33 $8.06 Million - $13.3 Million	-136,852 Reduced 49.48%	139,747 $9.57 Million
Q4 2020 Feb 12, 2021	BUY	$43.6 - $73.05 $4.43 Million - $7.42 Million	101,545 Added 58.01%	276,599 $18.6 Million
Q3 2020 Nov 12, 2020	BUY	$38.47 - $52.03 $1.33 Million - $1.8 Million	34,609 Added 24.64%	175,054 $9.01 Million
Q2 2020 Aug 13, 2020	BUY	$27.28 - $43.01 $15,304 - $24,128	561 Added 0.4%	140,445 $5.29 Million

Q1 2020 May 13, 2020	BUY	$23.08 - $35.53 $3,161 - $4,867	137 Added 0.1%	139,884 $4.17 Million
Q4 2019 Feb 14, 2020	BUY	$15.74 - $35.04 $1.18 Million - $2.62 Million	74,747 Added 115.0%	139,747 $4.8 Million
Q3 2019 Nov 14, 2019	BUY	$18.09 - $27.92 $1.18 Million - $1.81 Million	65,000 New	65,000 $1.18 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.